Trial intelligence / Profile preview

Salfaprodil in Acute Ischemic Stroke

NCT04486430Phase 2Completed

Sponsor
Beijing Tiantan Hospital
Start
Mar 2017
Primary completion
Jun 2019
Countries
1
01

Overview

A Phase 2 trial of salfaprodil in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Mar 2017; status: completed.

02

Drugs

salfaprodil
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT04486430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04486430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call